Families at risk of colon cancer II. Hereditary nonpolypous colorectal carcinoma;Rodiny s rizikom rakoviny hrubého čreva II. Hereditárny nepolypózny kolorektálny karcinóm

Vnitrni Lekarstvi

Volumn 50, Issue 8, 2004, Pages 606-614

  Hlavatý, Tibor ^a   Lukac L' ^a   Duris I ^a  

^a UK a FN ^*  (Slovakia)

Author keywords

Colorectal neoplasms; Genetic testing; Hereditary nonpolyposis colorectal cancer (HNPCC); Surveillance guidelines; Therapy

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; CANCER RISK; CANCER SCREENING; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; ENDOMETRIUM CANCER; FAMILY; GENE; GENE MUTATION; GENETIC SCREENING; GERM LINE; GYNECOLOGICAL EXAMINATION; HIGH RISK POPULATION; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MISMATCH REPAIR GENE; MORTALITY; PRACTICE GUIDELINE; REVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC SCREENING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 4444274243     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology, 2001; 121: 195-197
2. Aaltonen, L. A., Salovaara, R., Kristo, P. et al.: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. NEJM 1998; 338: 1481-1487
3. Aarnio, M., Sankila, R., Pukkala, E. et al.: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int. J. Cancer, 1999; 81: 214-218
4. Akiyama, Y., Iwanaga, R., Saitoh, K. et al.: Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology, 1997; 112: 33-39
5. Bartosova, Z., Fridrichova, I., Bujalkova, M. et al.: Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Hum. Mutat. 2003; 21: 449
6. Beck, N. E., Tomlinson, I. P., Homfray, T. et al.: Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. Hum. Genet., 1997; 99: 219-224
7. Bellacosa, A., Genuardi, M., Anti, M. et al.: Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects. Am. J. Med. Genet. 1996; 62: 353-364
8. Bertario, L., Aste, H., Arrigoni, A. et al.: Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC). Tumori, 1996; 82: 117-121
9. Bertario, L., Aste, H., Arrigoni, A. et al.: Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC). Tumori, 82: 117-121
10. Bertario, L., Russo, A., Sala, P. et al.: Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int. J. Cancer, 1999; 80: 183-187
11. Boks, D. E., Trujillo, A. P., Voogd, A. C. et al.: Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int. J. Cancer, 2002; 102: 198-200
12. Boland, C. R., Thibodeau, S. N., Hamilton, S. R. et al.: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 1998; 58: 5248-5257
13. Bronner, C. E., Baker, S. M., Morrison, P. T. et al.: Mutation in the DNA mismatch: repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 1994; 368: 258-261
14. Burke, W., Petersen, G., Lynch, P. et al.: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA, 1997; 277: 915-919.
15. de-Vos-tot-Nederveen-Cappel, W. H., Nagengast, F. M., Griffioen, G. et al.: Surveillance for hereditary non-polyposis colorectal cancer: a long-term study on 114 families. Dis. Colon Rectum, 2002; 46: 1588-1594.
16. Doležal, T., Panczak, A., Křepelová, A.: Přehled molekulární genetiky Lynchova syndromu. Čs. Fyziologie, 1998; 47: 4-12
17. Fishel, R., Lescoe, M. K., Rao, M. R. et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 1993; 75: 1027-1038
18. Foltin, J., Gutvirthova, L., Holý, P. et al.: Lynchův syndrom - přínos molekulárni genetiky k diagnostice pacientů nesplňujících ICG Amsterdamské kritéria. Čes. a Slov. Gastroent., 2003; 57: 57-60
19. Fridrichová, I., Ilenčiková, D., Friedl, W. et al.: Approaches to identification of HNPCC suspected patients in Slovak population. Neoplasma, 2000; 47: 219-226
20. Hadley, D. W., Jenkins, J., Dimond, E. et al.: Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch. Intern. Med., 2003; 163: 573-582
21. Hamilton, S. R., Liu, B., Parsons, R. E. et al.: The molecular basis of Turcot's syndrome. NEJM, 1995; 332: 839-847
22. Christensen, M., Katballe, N., Wikman, F. et al.: Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer, 2002; 95: 2422-2430
23. Jablonská, M., Křepelovà, A., Hajer, J.: Nové aspekty Lynchova syndromu. Čes. a Slov. Gastroent., 1997; 51: 210-213
24. Jarvinen, H. J., Aarnio, M., Mustonen, H. et al.: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 2000; 118: 829-834
25. Jarvinen, H. J., Mecklin, J. P., Sistonen, P.: Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 1995; 108: 1405-1411
26. Krutílková, V., Havlovičová, M., Goetz, P.: Špeciální genetické poradenství u pediatrických a dospělých onkologických pacientů. Čas. Lék. čes., 2002; 141: 23-27
27. Liu, T., Wahlberg, S., Rubio, C. et al.: DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. Clin. Genet., 1998; 53: 131-135
28. Lynch, H. T., de la Chapelle, A.: Hereditary colorectal cancer. NEJM, 2003; 348: 919-932
29. Lynch, H. T., Leibowitz, R., Smyrk, T. et al.: Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review. Am. J. Gastroenterol., 1999; 94: 575-580
30. Lynch, H. T., Lynch, J. F.: Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies. Biochimie, 2002; 84: 3-17
31. Lynch, H. T., Shaw, M. W., Magnuson, C. W. et al.: Hereditary factors in cancer. Study of two large midwestern kindreds. Arch. Intern. Med. 1966; 117: 206-212
32. Lynch, H. T., Smyrk, T., Lynch, J.: An update of HNPCC (Lynch syndrome). Cancer Genet. Cytogenet., 1997; 93: 84-99
33. Lynch, H. T., Smyrk, T. C., Watson, P. et al.: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology, 1993; 104: 1535-1549
34. Miyaki, M., Konishi, M., Tanaka, K. et al.: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet., 1997; 17: 271-272
35. Nicolaides, N. C., Papadopoulos, N., Liu, B. et al.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80
36. Osmers, R., Volksen, M., Schauer, A.: Vaginosonography for early detection of endometrial carcinoma? Lancet, 1990; 335: 1569-1571
37. Peltomaki, P., Vasen, H. F.: Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology, 1997; 113: 1146-1158
38. Pecterson, S. K., Watts, B. G., Koehly, L. M. et al.: How families communicate about HNPCC genetic testing: Findings from a qualitative study. Am. J. Med. Genet., 2003; 119C: 78-86
39. Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R. et al.: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst., 1997; 89: 1758-1762
40. Selby, J. V., Friedman, G. D., Quesenberry, C. P., Jr. et al.: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. NEJM, 1992; 326: 653-657
41. Strand, M., Prolla, T. A., Liskay, R. M. et al.: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature, 1993; 365: 274-276
42. Syngal, S., Fox, E. A., Eng, C. et al.: Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J. Med. Genet., 2000; 37: 641-645
43. Terdiman, J. P., Conrad, P. G., Sleisenger, M. H.: Genetic testing in hereditary colorectal cancer: indications and procedures. Am. J. Gastroenterol. 1999; 94: 2344-2356
44. Thibodeau, S. N., Bren, G., Schaid, D.: Microsatellite instability in cancer of the proximal colon. Science, 1993; 260: 816-819
45. Van-den-Bosch, T., Vandendael, A., Van-Schoubroeck, D. et al.: Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet. Gynecol., 1995; 85: 349-352
46. Vasen, H. F., Mecklin, J. P., Khan, P. M. et al.: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum, 1991; 34: 424-425
47. Vasen, H. F., Nagengast, F. M., Khan, P. M.: Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet, 1995; 345: 1183-1184
48. Vasen, H. F., van-Ballegooijen, M., Buskens, E. et al.: A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer, 1998; 82: 1632-1637
49. Vasen, H. F., Watson, P., Mecklin, J. P. et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 1999; 116: 1453-1456
50. Voskuil, D. W., Vasen, H. F., Kampman, E. et al.: Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int. J. Cancer, 1997; 72: 205-209
51. Wiggins, S., Whyte, P., Huggins, M. et al.: The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. NEJM, 1992; 327: 1401-1405
52. Winawer, S., Fletcher, R., Rex, D. et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology, 2003; 124: 544-560
53. Yagi, O. K., Akiyama, Y., Nomizu, T. et al.: Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology, 1998; 114: 268-274